Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially impacting companies like Dr Reddy's Laboratories, Zydus, and Cipla.

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...

(Image Credits: Pixabay) Zydus Lifesciences Ltd on Tuesday announced that it has entered into an agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR tablets used in treatment of ...

Pankaj Patel, Chairman of Zydus Lifesciences, has been awarded the prestigious Padma Bhushan for his contributions to the Indian lifesciences industry. Patel has steered Zydus towards innovation and ...